Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. [electronic resource]
Producer: 20160219ISSN:- 1460-2105
- Aged
- Double-Blind Method
- Drug Administration Schedule
- Endometrial Neoplasms -- chemically induced
- Estrogen Replacement Therapy -- adverse effects
- Estrogens, Conjugated (USP) -- administration & dosage
- Female
- Humans
- Hysterectomy
- Incidence
- Kaplan-Meier Estimate
- Medroxyprogesterone Acetate -- administration & dosage
- Middle Aged
- Odds Ratio
- Postmenopause
- United States -- epidemiology
- Women's Health
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.